Knight Therapeutics's total assets for Q3 2025 were C$1.05B, an increase of 1.02% from the previous quarter. KHTRF total liabilities were C$281.78M for the fiscal quarter, a 2.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.